{"id":5465,"date":"2022-03-15T09:00:00","date_gmt":"2022-03-15T08:00:00","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/stayble-therapeutics-presenterade-pa-aktiedagen-stockholm-2022\/"},"modified":"2022-03-15T09:00:00","modified_gmt":"2022-03-15T08:00:00","slug":"stayble-therapeutics-presenterade-pa-aktiedagen-stockholm-2022","status":"publish","type":"cision-feed","link":"https:\/\/staybletherapeutics.com\/sv\/cision-feed\/stayble-therapeutics-presenterade-pa-aktiedagen-stockholm-2022\/","title":{"rendered":"Stayble Therapeutics presenterade p\u00e5 Aktiedagen Stockholm 2022"},"content":{"rendered":"<p style=\"text-align:justify;margin-top:12px\"><span><span style=\"font-size:9pt\"><span><span style=\"color:#3b3838\"><span><span style=\"font-family:arial,helvetica,sans-serif\">VD Andreas Gerward presenterade Bolaget, utvecklingen av injektionsbehandlingen STA363 mot kronisk diskrelaterad ryggsm\u00e4rta, samt uppdaterade om den p\u00e5g\u00e5ende kliniska fas 2b-studien. <\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p style=\"text-align:justify\"><span><span style=\"font-size:9pt\"><span><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"color:#3b3838\">Presentationen fr\u00e5n den 14 mars finns tillg\u00e4nglig p\u00e5 f\u00f6ljande l\u00e4nk: <a href=\"https:\/\/youtu.be\/yevDh5o0WgI\" style=\"color:blue;text-decoration:underline\">https:\/\/youtu.be\/yevDh5o0WgI<\/a> <\/span><\/span><\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Stayble Therapeutics VD Andreas Gerward h\u00f6ll den 14 mars 2022 en presentation p\u00e5 Aktiedagen Stockholm 2022, vilket \u00e4r ett evenemang arrangerat av Aktiespararna.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5465"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/cision-feed"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5465"}],"version-history":[{"count":0,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/cision-feed\/5465\/revisions"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5465"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}